Live Breaking News & Updates on Professor Li Jianyong

Stay updated with breaking news from Professor li jianyong. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

AstraZeneca Calquence approved in China for chronic lymphocytic leukaemia

Cambridge: AstraZeneca’s Calquence (acalabrutinib), a next generation, selective Bruton’s tyrosine kinase (BTK) inhibitor, has been approved in China for the treatment of adult patients with chronic. ....

Dave Fredrickson , Li Jianyong , National Medical Products Administration , Jiangsu Province , Executive Vice President , Oncology Business Unit , Astrazeneca News , Lymphocytic Leukaemia , Professor Li Jianyong ,